Serological and molecular diagnosis

Seminars in Liver Disease

Volumn 26, Issue 2, 2006, Pages 97-103

  Bowden, Scott ^a,b  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

HBV DNA amplification assays; Hepatitis B serology; Hepatitis B virus DNA

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS DNA;

ACUTE HEPATITIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASSAY; CHRONIC HEPATITIS; DIAGNOSTIC KIT; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE AMPLIFICATION; HEPATITIS B; HEPATITIS B VIRUS; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER FUNCTION TEST; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEROLOGY; VIRUS DETECTION; VIRUS HEPATITIS; VIRUS LOAD; VIRUS REPLICATION;

DIAGNOSIS, DIFFERENTIAL; DNA, VIRAL; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SEROLOGIC TESTS;

EID: 33646366401     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-939756     Document Type: Review

References (38)

1. Blumberg BS, Alter HJ, Visnich SA. "New" antigen in leukemia sera. JAMA 1965;191:S41-S46
2. Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1981;1:377-385
3. Dane DS, Cameron CH, Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet 1970;1:695-698
4. Hollinger FBLT. Hepatitis B Virus. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2001
5. Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A 1990;87:6S99-6603.
6. Harrison TJ. Hepatitis B virus: molecular virology and common mutants. Semin Liver Dis 2006;26:87-96
7. Lok AS, Akarca U, Greene S. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc Natl Acad Sci U S A 1994;91:4077-4081
8. Okamoto H, Tsuda F, Akahane Y, et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 1994; 68:8102-8110
9. Sherlock S. Virus hepatitis B, A, non-A, non-B. J Hepatol 1989;8:254-258
10. Fagan EA, Williams R. Fulminant viral hepatitis. Br Med Bull 1990;46:462-480
11. Biswas R, Tabor E, Hsia CC, et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003;43:788-798
12. Pfeifer K, Pelzer C, Coleman P, Pope M, Kapprell HP. Early detection of hepatitis B surface antigen-prototype of a new fully automated HBsAg microparticle enzyme immunoassay (MEIA). Clin Lab 2003;49:161-166
13. Bowden S. Laboratory Diagnosis of Hepatitis B Infection. 1st ed. London: International Medical Press; 2002
14. Wieland SF, Chisari. FV. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 2005;79:9369-9380
15. Laras A, Koskinas J, Hadziyannis SJ. In vivo suppression of precore mRNA synthesis is associated with mutations in the hepatitis B virus core promoter. Virology 2002;295:86-96
16. Hadziyannis SJ, Papatheodoridis GV, Vassilopoulos D. Treatment of HBeAg-negative chronic hepatitis B. Semin Liver Dis 2003;23:81-88
17. Sjogren M, Hoofnagle JH. Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis. Gastroenterology 1985;89:252-258
18. Tassopoulos NC, Papatheodoridis GV, Kalantzakis Y, et al. Differential diagnosis of acute HBsAg positive hepatitis using IgM anti-HBc by a rapid, fully automated microparticle enzyme immunoassay. J Hepatol 1997;26:14-19
19. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001;34:194-203
20. Hu KCX Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 2002;9:243-257
21. Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 2001;80:63-71
22. Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 2005-97:265-272
23. Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci U S A 1996;93:4398-4402
24. Zeuzem S, de Man RA, Honkoop P, Roth WK, Schalm SW, Schmidt JM. Dynamics of hepatitis B virus infection in vivo. J Hepatol 1997;27:431-436
25. Lewin SR, Ribeiro RM, Walters T, et al. Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed. Hepatology 2001;34:1012-1020
26. Locarnini S, Hatzakis A, Heathcote J, et al. Management of antiviral resistance in patients with chronic hepatitis B. Antivir Ther 2004;9:679-693
27. Pawlotsky JM. Molecular diagnosis of viral hepatitis. Gastroenterology 2002;122:1554-1568
28. Newbold JE, Xin H, Tencza M, et al. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol 1995;69:3350-3357
29. Bock CT, Schranz P, Schroder CH, Zentgraf H. Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes 1994;8:215-229
30. Summers J, Mason WS. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 1982;29:403-415
31. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000;64:S1-68
32. Tuttleman JS, Pourcel C, Summers J. Formation of the pool of covalendy closed circular viral DNA in hepadnavirus-infected cells. Cell 1986;47:4S1-460
33. Wu TT, Coates L, Aldrich CE, Summers J, Mason WS. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology 1990;175:255-261
34. Jun-Bin S, Zhi C, Wei-Qin N, Jun F. A quantitative method to detect HBV cccDNA by chimeric primer and real-time polymerase chain reaction. J Virol Methods 2003;l12:45-52
35. Kock J, Theilmann L, Galle P, Schlicht HJ. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. Hepatology 1996;23:405-413
36. Sung JJ, Wong ML, Bowden S, et al. Intrahepatic hepatitis B virus covalendy closed circular DNA can be a predictor of sustained response to therapy. Gastroenterology 2005;128: 1890-1897
37. Werle-Lapostolle B, Bowden S, Locarnini S, et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004;126:1750-1758
38. Hui CK, Bowden S, Jackson K, et al. Clinical significance of intrahepatic hepatitis B virus covalently closed circular DNA in chronic hepatitis B patients who received cytotoxic chemotherapy. Blood 2005;105:2616-2617